Recent Updates
Recently added Catalysts
JNJ

Johnson & Johnson to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference Johnson & Johnson (NYSE: JNJ) will participate in the Goldman Sachs 43rd Annual Global Healthcare Conference at the Terranea Resort, Rancho Palos...

Key Takeaway: NEW BRUNSWICK, N.J. , May 12, 2022 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ ) will participate in the Goldman Sachs 43 rd Annual Global Healthcare Conference at the Terranea Resort, Rancho Palos Verdes, CA on Thursday, June 16 th . Jennifer Taubert , Executive Vice President,
Price reaction · baseline $176.13 (2022-05-11 close) · hit after-hours · clean, no other JNJ news in the window
day 0 close · peak
+1%

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+34%
120-day peak, hindsight
Typical move
1.6%
average across 15 past catalysts
Lead asset
Canagliflozin
Phase 3 · Diabetes Mellitus, Type 2

Full Press Release Details

NEW BRUNSWICK, N.J. , May 12, 2022 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ ) will participate in the Goldman Sachs 43 rd Annual Global Healthcare Conference at the Terranea Resort, Rancho Palos Verdes, CA on Thursday, June 16 th . Jennifer Taubert , Executive Vice President, Worldwide Chairman, Pharmaceuticals will represent the Company in a session scheduled at 1:00 p.m. (Eastern Time) .
This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com .
A webcast replay will be available approximately 48 hours after the live webcast.
Last updated: May 12, 2022